|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01681 CONSUN PHARMA
Nominal 
8.600 +0.120 (+1.415%) Ranking Overview
Ranking based on 2 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
2
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 99.00 RMB (cts) | |
| Net Profit | 784.53 RMB (MIL) | DPS | 40.81 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 877.50 | 109.50 | 37.35 | -- | 889.00 | 866.00 |
| 2025 | 1,009.50 | 126.00 | 43.26 | -- | 1,010.00 | 1,009.00 |
| 2026 | 1,152.00 | 143.50 | 49.42 | -- | 1,163.00 | 1,141.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 866.00 | 107.00 | 41.78 | DBS VICKERS | Buy | 7.80 | 03/06/2024 | |
| 2024 | 889.00 | 112.00 | 32.91 | ESSENCE INT'L SEC | ADD | 5.90 | 20/06/2024 | |
| 2025 | 1,009.00 | 124.00 | 49.04 | DBS VICKERS | -- | -- | 03/06/2024 | |
| 2025 | 1,010.00 | 128.00 | 37.47 | ESSENCE INT'L SEC | -- | -- | 20/06/2024 | |
| 2026 | 1,163.00 | 143.00 | 56.31 | DBS VICKERS | -- | -- | 03/06/2024 | |
| 2026 | 1,141.00 | 144.00 | 42.53 | ESSENCE INT'L SEC | -- | -- | 20/06/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 08/11/2024 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 399,765 |
| %Change | 14.910% |
| EPS / (LPS) | RMB 0.499 |
| NBV Per Share (¥) | RMB 4.383 |